Asia Pacific Smart Biopsy Market By Application (Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others) By Country, Industry Analysis and Forecast, 2019 - 2025
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Smart Biopsy Market
Market Report Description
The Asia Pacific Smart Biopsy Market would witness market growth of 6.58% CAGR during the forecast period (2019-2025). According to the World Cancer Report, there will be 15 million additional cases of cancer by the end of 2020. The worldwide pervasiveness of cancer diseases like lung cancer, breast cancer, prostate cancer, etc., would drive the market scenario. People are more health-conscious these days and switch to minimally invasive techniques over traditional techniques in order to ensure complete security.
Current diagnostic tools for cancer involve invasive procedures like biopsies. However, if the lesion was better defined, such painful procedures could be avoided in many cases. In addition, the increased costs of these invasive biopsies and their association with painful procedures often put patients in a position of avoiding or delaying the procedure. This leads to an insufficient diagnosis of people or diagnosis of patients at a later stage of the disease.
The Asia- Pacific region is anticipated to experience the highest growth rate over the forecast period. This rapid growth rate can be attributed to extensive government initiatives, healthcare spending, cancer awareness campaigns, and the availability of technologically advanced smart biopsy devices. The Indian Government has announced two major initiatives in the healthcare sector, namely the Ayushman Bharat Program and the National Health Protection Scheme.
Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: Smart Biopsy Market in Asia Pacific is expected to register a CAGR of 6.58% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.
Scope of the Smart Biopsy Market Analysis
Market Segmentation:
By Application
- Breast cancer
- Skin cancer
- Liver cancer
- Prostate cancer and
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Danaher Corporation
- Argon Medical Devices, Inc.
- Cardinal Health, Inc.
- Canon, Inc. (Canon Medical Systems Corporation)
- Boston Scientific Corporation
- Olympus Corporation
- Hologic, Inc.
- B. Braun Melsungen AG
- Cook Medical, Inc. (Cook Group)
- Medtronic Plc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free